CIC Questions Bank

The Certification Study Guide (6th edition) explains that bioterrorism agents are categorized by the Centers for Disease Control and Prevention (CDC) into Categories A, B, and C based on their potential impact on public health. Category A agents represent the highest priority because they pose a severe threat to national security and public health. These agents are characterized by ease of dissemination or transmission, high mortality rates, potential for major public health impact, and the ability to cause public panic and social disruption.

Smallpox (variola virus) is a classic and well-recognized Category A bioterrorism agent. The study guide emphasizes that although naturally occurring smallpox has been eradicated globally, the virus remains a major concern because the general population lacks immunity, person-to-person transmission is efficient, and outbreaks would require extensive public health response. Smallpox also necessitates strict isolation precautions and rapid vaccination strategies during suspected or confirmed cases.

The other options fall into lower categories. Q fever and brucellosis are classified as Category B agents, as they are moderately easy to disseminate but typically cause lower mortality rates. Influenza, while capable of causing pandemics, is not classified as a bioterrorism Category A agent.

Understanding bioterrorism classifications is essential for infection preventionists, particularly in emergency preparedness, surveillance, and response planning—key knowledge areas emphasized on the CIC exam.

The Certification Study Guide (6th edition) emphasizes that process performance indicators directly linked to evidence-based practices are the most effective measures for reducing healthcare-associated infections such as CLABSI. Among the options listed, 100% compliance with the central line insertion bundle is the only indicator consistently demonstrated to reduce CLABSI rates.

Insertion bundles are standardized sets of practices that include proper hand hygiene, maximal sterile barrier precautions, use of appropriate skin antisepsis (preferably chlorhexidine), optimal catheter site selection, and daily review of line necessity. The study guide explains that reliable execution of these bundled practices addresses the most common routes of microbial entry at the time of line placement, which is a critical risk period for bloodstream infection.

The other options do not represent valid improvement indicators. Total parenteral nutrition is a known risk factor for CLABSI, not a prevention strategy. Use of povidone-iodine ointment at insertion sites is not recommended and may increase infection risk. Routine guidewire exchanges are discouraged because they do not reduce infection risk and may increase contamination.

Therefore, measuring and achieving full compliance with the insertion bundle is a meaningful, actionable performance indicator that aligns with CBIC exam expectations and infection prevention best practices.

The table separates admission cultures from weekly cultures, which is a common surveillance approach to distinguish imported MRSA burden (present on admission) from healthcare acquisition (newly detected later). The admission culture percent positive rises over the three months: 14% (Feb) → 18% (Mar) → 19% (Apr). That pattern indicates an increasing admission prevalence (option B). NHSN MDRO surveillance methods describe admission prevalence as a proxy measure using admission-related data to quantify organisms present at the time of entry into a location/facility.

By contrast, weekly culture positivity—often used as a proxy for on-unit acquisition/transmission when admission screening is in place—decreases: 6% → 5.6% → 4%, so option A is not increasing. The dataset also does not provide information about MRSA infections versus colonization (so C cannot be concluded), nor does it provide a denominator for “compliance” (e.g., expected admissions/weekly screens completed), so D cannot be determined. This interpretation aligns with standard infection prevention use of MRSA surveillance data to track prevalence (burden) versus incidence/acquisition.

The CBIC Certified Infection Control Exam Study Guide (6th edition) highlights that consumption of raw or undercooked shellfish, particularly imported shellfish, is a well-recognized risk factor for waterborne and foodborne Vibrio infections, including Vibrio cholerae. The organism thrives in warm coastal waters and can contaminate shellfish harvested from endemic or inadequately regulated regions.

The clinical presentation described—profuse watery diarrhea occurring approximately 48 hours after exposure—is classic for Vibrio cholerae. The organism produces cholera toxin, which causes rapid fluid secretion into the intestinal lumen, resulting in large-volume watery stools. The incubation period typically ranges from a few hours to five days, making a 48-hour onset highly consistent with this pathogen.

The other options are less likely based on incubation period and symptom profile. Hepatitis A virus has an incubation period of weeks and presents with jaundice rather than acute watery diarrhea. Staphylococcus aureus food poisoning causes rapid onset (1–6 hours) due to preformed toxin and is commonly associated with vomiting. Listeria monocytogenes typically causes invasive disease rather than acute watery diarrhea and has a longer incubation period.

For CIC® exam preparation, recognizing shellfish-associated watery diarrhea with short incubation as characteristic of Vibrio cholerae is essential, particularly in outbreak investigations involving imported seafood.